Julie Louise Gerberding is the President and CEO of the Foundation for the National Institutes of Health (FNIH), a non-profit organization that builds public-private research partnerships to support the mission of the NIH. She co-chairs the CSIS Bipartisan Alliance on Global Health Security and is a member of the Commonwealth Fund Commission on a National Public Health System. Previously, she served as President of Merck Vaccines and as Executive Vice President and the Chief Patient Officer at Merck & Co., Inc. From 2003-2009, Julie led the U.S. Centers for Disease Control and Prevention (CDC).
She serves on the boards of HilleVax, Mayo Clinic, National Health Council, and Case Western Reserve University. Gerberding is a member of the National Academy of Medicine and the adjunct faculties of the University of California, San Francisco, and Case Western Reserve University.
